新生儿输血是临床诊治中非常重要的治疗措施,也是抢救、治疗某些新生儿疾病的有效治疗手段。新生儿生后常有诸多疾病需要应用输血治疗。如急性失血、围手术期输血、贫血等。但我国目前新生儿输血多来源于异体成人血,其治疗过程中存在一定的感染风险、移植物抗宿主病风险、过敏风险等。为了进一步减少输血风险,合理使用血制品,减少血制品的浪费,近年来国外已开展了新生儿脐血 Neonatal blood transfusion is a very important treatment in clinical diagnosis and treatment, but also an effective treatment for the treatment of some newborn diseases. Many newborns often require blood transfusions after birth. Such as acute blood loss, perioperative blood transfusion, anemia and so on. However, most newborn blood transfusions in our country originate from allogeneic adult blood, and there is a certain risk of infection, graft-versus-host disease and allergy risk in the course of treatment. In order to further reduce the risk of blood transfusion, the rational use of blood products, reduce the waste of blood products, foreign countries have carried out in recent years, neonatal cord blood